Rapid Communication Hospital and Outpatient Health Services Utilization Among HIV‐Infected Patients in Care in 1999

Background: The evolving epidemiology and therapeutic management of HIV disease has important implications for health care resource utilization in HIV‐infected patients, and health care resource use data are also needed to support policy and financial decision making. Methods: Demographic, clinical, and resource utilization data were collected from 9 U.S. HIV primary and specialty care sites in calendar year 1999. Rates of resource use were calculated for hospital admission, length of hospital stay, and outpatient clinic/office visits. Results: The sample included 5255 patients from HIV primary care sites in 3 eastern, 3 midwestern, and 3 western areas of the United States. Hospital admissions accounted for an annual mean of 297 days per 100 persons/y in 1999. Hospital days ranged from a low of 165 per 100 persons/mo for a CD4 > 500 cells/mm3 to 840 per 100 persons/mo for a CD4 < 50 cells/mm3 (p < .01). Mean annual outpatient clinic/office visits were 10.7 per person in 1999. A declining CD4 level and an increasing HIV‐1 RNA level were both associated with higher hospital and outpatient utilization. HAART use was associated with fewer hospital days, and a higher outpatient visit rate. Injecting drug use risk was associated with an increase in hospital days. African American race was associated with a higher number of hospital days, but a lower outpatient visit rate. Female gender was associated with higher outpatient utilization. Mean monthly inpatient and outpatient expenditures in 1999 were $423 and $168. respectively. Conclusion: As HIV care continues to evolve, data from our network of HIV providers will be useful in quantifying changes in HIV health services utilization to guide policy makers, as well as HIV care payers and providers.

[1]  M. Puoti,et al.  Mortality due to chronic viral liver disease among patients infected with human immunodeficiency virus. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M C Weinstein,et al.  The cost effectiveness of combination antiretroviral therapy for HIV disease. , 2001, The New England journal of medicine.

[3]  D. McCaffrey,et al.  Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. , 2001, The New England journal of medicine.

[4]  Mari M. Kitahata,et al.  Physician experience in the care of HIV-infected persons is associated with earlier adoption of new antiretroviral therapy. , 2000 .

[5]  M Egger,et al.  AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. , 1999, JAMA.

[6]  R. Chaisson,et al.  Natural history of HIV infection in the era of combination antiretroviral therapy. , 1999, AIDS.

[7]  Richard D Moore,et al.  Costs of HIV medical care in the era of highly active antiretroviral therapy. , 1999, AIDS.

[8]  D. McCaffrey,et al.  The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. , 1998, The New England journal of medicine.

[9]  V. M. Shadle,et al.  Self-reported antiretroviral therapy in injection drug users. , 1998, JAMA.

[10]  B. Yip,et al.  Barriers to use of free antiretroviral therapy in injection drug users. , 1998, JAMA.

[11]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[12]  R. A. Torres,et al.  Impact of combination therapy for HIV infection on inpatient census. , 1997, The New England journal of medicine.

[13]  R. Chaisson,et al.  Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[14]  N. Weiss,et al.  HIV infection and vaginal douching in Central Africa , 1997, AIDS.

[15]  T. Koepsell,et al.  Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. , 1996, The New England journal of medicine.

[16]  F J Hellinger,et al.  The lifetime cost of treating a person with HIV. , 1993, JAMA.

[17]  P. Lee,et al.  Medical care costs of patients with AIDS in San Francisco. , 1986, JAMA.